Presence of intraductal carcinoma was not significantly associated with patient race, preoperative PSA level, clinical stage, fraction of biopsy cores involved by cancer, or presence of bilateral disease on biopsy. This evidence concerns the gene KLK3 and ductal breast carcinoma in situ.